Health effects classification and its role in the derivation of minimal risk levels: Renal effects-Reference-Cited by-同舟云学术

Health effects classification and its role in the derivation of minimal risk levels: Renal effects

Published:2005-07 Issue:2 Volume:42 Page:202-208
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Chou C.-H. Selene J.,Pohl Hana R.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference40 articles.

1. The use of hematological effects in the development of minimal risk levels;Abadin;Regul. Toxicol. Pharmacol.,1998

2. Toxicity of hexachlorocyclopentadiene: subchronic (13-week) administration by gavage of F344 rats and B6C3F1 mice;Abdo;J. Appl. Toxicol.,1984

3. ATSDR, 1996. Minimal risk levels for priority substances and guidance for derivation. Agency for Toxic Substances and Disease Registry. Federal Register 61, 33511–33520

4. ATSDR, 2003. Guidance for developing toxicological profiles (update). Agency for Toxic Substances and Disease Registry, U.S. Department of Health and Human Services, Atlanta, GA

5. Protein nephropathy and kidney cancer in male rats: qualitative and quantitative issues and human relevance;Borghoff;CIIT Activities,1991

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Noncancer Risk Assessment: Principles and Practice in Environmental and Occupational Settings;Patty's Toxicology;2023-12-19

2. Tolerable intake values for leachables: Practical use of ISO 10993-17 standard;Biocompatibility and Performance of Medical Devices;2020

3. Action levels for airborne uranium in the workplace: chemical and radiological assessments;Journal of Radiological Protection;2018-03-28

4. Noncancer Risk Assessment: Principles and Practice in Environmental and Occupational Settings;Patty's Toxicology;2012-08-17

5. Allowable limits for toxic leachables: practical use of ISO 10993-17 standard * *The recommendations offered in this chapter should not be construed as guidance from the US Food and Drug Administration (FDA). The mention of commercial products, their sources or their use in connection with material reported herein is not to be construed as either an actual or implied endorsement of such products by the Department of Health and Human Services.;Biocompatibility and Performance of Medical Devices;2012